ATE529117T1 - Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür - Google Patents

Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür

Info

Publication number
ATE529117T1
ATE529117T1 AT05765316T AT05765316T ATE529117T1 AT E529117 T1 ATE529117 T1 AT E529117T1 AT 05765316 T AT05765316 T AT 05765316T AT 05765316 T AT05765316 T AT 05765316T AT E529117 T1 ATE529117 T1 AT E529117T1
Authority
AT
Austria
Prior art keywords
azithromycin
water
production method
composition containing
medical composition
Prior art date
Application number
AT05765316T
Other languages
English (en)
Inventor
Hidekazu Suzuki
Kuniko Koichi
Kouhei Yoda
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Application granted granted Critical
Publication of ATE529117T1 publication Critical patent/ATE529117T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT05765316T 2004-07-02 2005-07-04 Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür ATE529117T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004196315 2004-07-02
PCT/JP2005/012327 WO2006004085A1 (ja) 2004-07-02 2005-07-04 アジスロマイシン含有水性医薬組成物及びその調製方法

Publications (1)

Publication Number Publication Date
ATE529117T1 true ATE529117T1 (de) 2011-11-15

Family

ID=35782886

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05765316T ATE529117T1 (de) 2004-07-02 2005-07-04 Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür

Country Status (6)

Country Link
US (1) US8153601B2 (de)
EP (1) EP1782816B1 (de)
JP (1) JP3933683B2 (de)
KR (1) KR101130252B1 (de)
AT (1) ATE529117T1 (de)
WO (1) WO2006004085A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
JP2007238607A (ja) * 2006-02-08 2007-09-20 Kawaken Fine Chem Co Ltd 塩素除去剤
US7795231B2 (en) * 2007-10-04 2010-09-14 Insite Vision Incorporated Concentrated aqueous azalide formulations
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
US20130281390A1 (en) * 2010-12-29 2013-10-24 Kurt E. Brubaker Method for treating dry eye
CA2823628A1 (en) 2011-01-05 2012-07-12 Hospira, Inc. Spray drying vancomycin
US20130172271A1 (en) * 2012-01-04 2013-07-04 Cynthia Fragale Pharmaceutical Spray Drying
CN102755287A (zh) * 2012-07-20 2012-10-31 天津药业集团新郑股份有限公司 阿奇霉素口服液及其制备方法
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
US11452732B2 (en) 2015-09-05 2022-09-27 Randal Davis Homogeneous ophthalmic composition
US10130639B1 (en) * 2015-09-05 2018-11-20 Randal Davis Homogeneous ophthalmic composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JP3147076B2 (ja) * 1997-03-14 2001-03-19 千寿製薬株式会社 ロテプレドノール エタボネート水性懸濁液
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
ES2221127T5 (es) 1997-12-02 2009-11-10 Pfizer Products Inc. Uso de acitromicina en el tratamiento topico de infecciones oculares.
US6239113B1 (en) 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
US6608033B1 (en) * 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
JP2001261552A (ja) * 2000-03-22 2001-09-26 Chisso Corp 点眼液用保存剤
HRP20010301A2 (en) * 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects

Also Published As

Publication number Publication date
US8153601B2 (en) 2012-04-10
EP1782816A1 (de) 2007-05-09
EP1782816A4 (de) 2008-08-27
US20070087980A1 (en) 2007-04-19
EP1782816B1 (de) 2011-10-19
KR20070039040A (ko) 2007-04-11
KR101130252B1 (ko) 2012-03-26
WO2006004085A1 (ja) 2006-01-12
JPWO2006004085A1 (ja) 2008-04-10
JP3933683B2 (ja) 2007-06-20

Similar Documents

Publication Publication Date Title
ATE529117T1 (de) Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür
MXPA03011039A (es) Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos.
EP1179341A4 (de) Heilmittel und vorbeugung für mit chemokinen verbundenen erkrankungen
ATE248837T1 (de) Chinuclidin-acrylamide
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
RS20050311A (en) Selected cgrp antagonists,method for production and use thereof as medicament
WO2004037811A8 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
EP1180518A4 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
TW200603799A (en) Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
PL377838A1 (pl) Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
SE0400043D0 (sv) New compounds
WO2009012375A3 (en) Squarate kinase inhibitors
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
ATE277062T1 (de) Neue makrolidderivate
DK1026170T3 (da) Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
NO933010L (no) 4-((2-benzotiazolyl)metylamino)alfa-((3,4-difluorfenoksy)metyl)-1-piperidinetanol
BR0303475A (pt) Sal cristalino do ácido adìpico da amlodipina, respectivo método de preparação e composição farmacêutica
EE200200599A (et) Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism
ATE294155T1 (de) Eine methode zur herstellung von verbindungen der formel 1 und derivaten
MXPA04002141A (es) Intermediarios para preparar conjugados inhibidores de la neuraminidasa.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties